Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)
Trial · NCT02072434
Participant flow12
How many started, completed or left each group, period by period.
1 to 12 of 12
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Edoxaban | 1,095 | |
| Overall Study | STARTED | Warfarin | 1,104 | |
| Overall Study | Intent to Treat Analysis Set | Edoxaban | 1,095 | |
| Overall Study | Intent to Treat Analysis Set | Warfarin | 1,104 | |
| Overall Study | Received Study Drug | Edoxaban | 1,067 | |
| Overall Study | Received Study Drug | Warfarin | 1,082 | |
| Overall Study | Safety Analysis Set | Edoxaban | 1,067 | |
| Overall Study | Safety Analysis Set | Warfarin | 1,082 | |
| Overall Study | COMPLETED | Edoxaban | 1,041 | |
| Overall Study | COMPLETED | Warfarin | 1,014 | |
| Overall Study | NOT COMPLETED | Edoxaban | 54 | |
| Overall Study | NOT COMPLETED | Warfarin | 90 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02072434/flow